SATB2 and inflammatory bowel disease: SATB2 downregulation has been reported in sessile serrated pathway‐associated colorectal carcinomas, IBD associated colorectal carcinomas and dysplasias,20, 21, 22 and here we reveal that it also occurs in SSLs and MVHPs (see Figure 2 and Table 2).